What Happened?
San Diego, CA-based Radionetics Appointed Umesh Gangadharmath as Senior Vice President of Technical Operations.
About the Company
Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications. The company`s platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes to a broad range of cancers by binding selectively to peptide receptors that are selectively expressed on these tumors. This nonpeptide technology addresses many of the significant challenges currently facing peptide and protein targeted radiotherapeutics, particularly in the realm of optimizing drug-like characteristics and manufacturing. The company is rapidly advancing a pipeline of drug candidates to treat a broad range of cancers and is conducting additional drug discovery efforts to identify drug candidates for additional receptor targets in collaboration with Crinetics Pharmaceuticals.
About the Person
Umesh Gangadharmath is Senior Vice President of Technical Operations. at Radionetics. Previously, Umesh held various senior IT leadership roles in the industry.
Info Source
News
Short Profile